Omega Healthcare Investors (NYSE:OHI) had its price target lifted by Raymond James from $42.00 to $44.00 in a report issued on Thursday, The Fly reports. They currently have a strong-buy rating on the real estate investment trust’s stock.

A number of other equities research analysts have also recently weighed in on the stock. Wells Fargo & Co upped their price objective on shares of Omega Healthcare Investors from $36.00 to $40.00 and gave the stock a market perform rating in a report on Friday, August 23rd. Zacks Investment Research cut shares of Omega Healthcare Investors from a buy rating to a hold rating in a report on Wednesday, August 21st. Seven equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $40.04.

Shares of NYSE OHI traded down $0.64 during midday trading on Thursday, hitting $40.52. 1,371,961 shares of the company traded hands, compared to its average volume of 1,689,256. Omega Healthcare Investors has a 12-month low of $31.69 and a 12-month high of $41.67. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78. The stock has a 50-day moving average price of $38.95 and a 200 day moving average price of $37.18. The firm has a market cap of $8.77 billion, a P/E ratio of 13.33, a P/E/G ratio of 5.33 and a beta of 0.37.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.39). The company had revenue of $191.81 million for the quarter, compared to analysts’ expectations of $190.46 million. Omega Healthcare Investors had a net margin of 29.38% and a return on equity of 6.79%. Omega Healthcare Investors’s quarterly revenue was down .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.75 EPS. As a group, equities analysts expect that Omega Healthcare Investors will post 2.96 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Wednesday, July 31st were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 6.52%. The ex-dividend date of this dividend was Tuesday, July 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 86.84%.

In other news, CFO Robert O. Stephenson sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $38.00, for a total value of $380,000.00. Following the transaction, the chief financial officer now owns 223,326 shares in the company, valued at $8,486,388. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO C Taylor Pickett sold 30,000 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $38.00, for a total transaction of $1,140,000.00. Following the completion of the transaction, the chief executive officer now owns 269,133 shares in the company, valued at approximately $10,227,054. The disclosure for this sale can be found here. In the last quarter, insiders sold 118,500 shares of company stock worth $4,586,300. Insiders own 1.16% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of OHI. Geode Capital Management LLC lifted its position in Omega Healthcare Investors by 8.0% during the fourth quarter. Geode Capital Management LLC now owns 2,312,184 shares of the real estate investment trust’s stock valued at $81,791,000 after purchasing an additional 171,333 shares during the period. Bank of Montreal Can lifted its position in Omega Healthcare Investors by 1.0% during the first quarter. Bank of Montreal Can now owns 49,995 shares of the real estate investment trust’s stock valued at $1,907,000 after purchasing an additional 507 shares during the period. State Board of Administration of Florida Retirement System lifted its position in Omega Healthcare Investors by 4.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 257,117 shares of the real estate investment trust’s stock valued at $9,809,000 after purchasing an additional 10,890 shares during the period. Nissay Asset Management Corp Japan ADV lifted its position in Omega Healthcare Investors by 6.3% during the first quarter. Nissay Asset Management Corp Japan ADV now owns 14,743 shares of the real estate investment trust’s stock valued at $562,000 after purchasing an additional 869 shares during the period. Finally, First Allied Advisory Services Inc. lifted its position in Omega Healthcare Investors by 72.1% during the first quarter. First Allied Advisory Services Inc. now owns 22,042 shares of the real estate investment trust’s stock valued at $842,000 after purchasing an additional 9,231 shares during the period. Hedge funds and other institutional investors own 69.94% of the company’s stock.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: Cost of Goods Sold (COGS)

The Fly

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.